247 related articles for article (PubMed ID: 37697692)
1. Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets.
Liu L; Lu L; Qiu M; Han N; Dai S; Shi S; He S; Zhang J; Yan Q; Chen S
Int Wound J; 2024 Jan; 21(1):e14384. PubMed ID: 37697692
[TBL] [Abstract][Full Text] [Related]
2. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
3. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.
Zhang T; Wang XF; Wang ZC; Lou D; Fang QQ; Hu YY; Zhao WY; Zhang LY; Wu LH; Tan WQ
Biomed Pharmacother; 2020 Sep; 129():110287. PubMed ID: 32540643
[TBL] [Abstract][Full Text] [Related]
4. Reconstructed human keloid models show heterogeneity within keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
[TBL] [Abstract][Full Text] [Related]
5. The role of altered fatty acid in pathological scars and their dermal fibroblasts.
Yang JX; Li SY; Chen ML; He LR
Chin J Traumatol; 2022 Jul; 25(4):218-223. PubMed ID: 35478090
[TBL] [Abstract][Full Text] [Related]
6. Toward understanding scarless skin wound healing and pathological scarring.
Karppinen SM; Heljasvaara R; Gullberg D; Tasanen K; Pihlajaniemi T
F1000Res; 2019; 8():. PubMed ID: 31231509
[TBL] [Abstract][Full Text] [Related]
7. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of keloid and hypertrophic scar formation.
Tuan TL; Nichter LS
Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
[TBL] [Abstract][Full Text] [Related]
9. Keloids: Animal models and pathologic equivalents to study tissue fibrosis.
Marttala J; Andrews JP; Rosenbloom J; Uitto J
Matrix Biol; 2016 Apr; 51():47-54. PubMed ID: 26827712
[TBL] [Abstract][Full Text] [Related]
10. Role of Inflammasomes in Keloids and Hypertrophic Scars-Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis.
Huang C; Ogawa R
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743263
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of hypertrophic scars and keloids].
Aschoff R
Hautarzt; 2014 Dec; 65(12):1067-77; quiz 1078-9. PubMed ID: 25412721
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
15. Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling.
Yuan R; Dai X; Li Y; Li C; Liu L
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476508
[TBL] [Abstract][Full Text] [Related]
16. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
Lee HJ; Jang YJ
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
18. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
Slemp AE; Kirschner RE
Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
[TBL] [Abstract][Full Text] [Related]
19. Interplay Between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders.
Russo B; Brembilla NC; Chizzolini C
Front Immunol; 2020; 11():648. PubMed ID: 32477322
[No Abstract] [Full Text] [Related]
20. Identification of a novel mutation in the mechanoreceptor-encoding gene CXCR1 in patients with keloid.
Zhang Q; Cai L; Wang M; Ke X; Zhao X; Huang Y
Arch Dermatol Res; 2018 Sep; 310(7):561-566. PubMed ID: 29931443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
